Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
about
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couplesSocial and Genetic Networks of HIV-1 Transmission in New York CityGenomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposureMolecular epidemiology of HIV-1 transmission in a cohort of HIV-1 concordant heterosexual couples from Dakar, SenegalMOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping.Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in AfricansHIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.Molecular tools for studying HIV transmission in sexual networks.Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples.An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in UgandaPreexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionPhylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?Improved detection of rare HIV-1 variants using 454 pyrosequencing.Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialPhylogenetic relatedness of circulating HIV-1C variants in Mochudi, BotswanaHost genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trialApplications of next-generation sequencing technologies to diagnostic virology.Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships.Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples.Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.Phylogenetically resolving epidemiologic linkage.An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.Future of phylogeny in HIV prevention.PANGEA-HIV: phylogenetics for generalised epidemics in Africa.HIV transmission: time for translational studies to bridge the gap.Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventionsMolecular linkage tracing of HIV-1 transmission events in seroconcordant couples in Guangxi Province, Southeastern ChinaChallenges in virological diagnosis of HIV -1 transmission from sexual abuse--HIV-1 genetic links are mandatory.HIV Incidence and Predictors of HIV Acquisition From an Outside Partner in Serodiscordant Couples in Lusaka, Zambia.HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences.Strengthening HIV surveillance: measurements to track the epidemic in real time.Improving vaccine trials in infectious disease emergencies.Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering.
P2860
Q21144606-11BF0AD7-DA17-4E24-829A-B35303E5F1F3Q28468363-24BBAD7C-07F4-4008-B184-680C55B14F5AQ29417004-4185CA82-40A1-4463-95C0-9C41D566916AQ31062029-A8BBEFF7-6839-4989-ADE7-BBE0AFF15EC9Q31153287-2016BEE7-63D2-4979-B43A-6BE1B6470BA5Q33630030-E5FD71D1-716F-4354-814C-7A4B7E3AA4ECQ33874874-3454E459-F825-48CE-8ED0-DB457E7A3335Q33945571-C1B800CC-8B71-4C01-BED4-975893914FB4Q34030252-B7FA94C8-23BB-4631-8F27-AEB6A261CDE4Q34314648-E97208A5-6EE4-4EF4-B04E-85BC1D2FDBDCQ34700364-7D11B579-47F8-4688-92DA-CE233F83A92BQ35006672-671128EC-2A80-44E7-8FB5-5232F5B11BB3Q35009489-5C39FA1C-271A-4222-A3AB-7E0950546037Q35043592-0309A016-9B91-4360-B0B9-A743B840E8BDQ35069391-9EF3E67D-04CD-4713-B3BC-669015023328Q35115540-D6F02AF2-55AB-4836-B986-4647BBD6E52FQ35214337-60571462-1F69-4328-A893-CB48CF3F97B6Q35532840-708C3811-1D66-4FE5-AF7A-D7C18FABE60EQ35600172-8C69753E-F42B-45FB-8283-5CB18C10349AQ35613315-7CA33A7F-757A-4C71-AF94-28F955C098D0Q35639676-F6AF3BBE-24C3-4F89-AA3C-57F6D97739FDQ35661895-F12E6AE8-28D3-4543-8C85-AE883B75CFECQ35699938-69B8BB12-43A8-402C-ADB9-B5FD64603D5DQ35751134-9D0E4788-FC49-4DA3-BE26-6D9E8799AE53Q36253005-399598E3-224D-44EC-A9B7-66F5B885B36AQ36497840-661E24B8-DFC8-4018-AF49-C41CC91CCDE4Q36509600-9DC3F421-D746-49AE-A1BF-952D1EEAD8F1Q36684805-12133ECC-C998-47C3-A3DF-68E05E058DDDQ36750843-EFF7DF3A-D112-46B4-A2C0-35F041367E87Q36945699-CDF46B8C-E81C-43C4-A001-49730BB1E51EQ37142571-5BF5894E-E40D-4730-BED8-096E1BC36340Q37156924-22949677-7DE3-408C-9CAA-3FD18643CFEAQ37206422-68752042-BFE9-47B7-8124-15C78FFD1659Q37442115-A6A28859-E22F-425D-AC5D-A03C3FF8D404Q38079656-0B9989D1-6040-48D9-A07C-5DF7CBF962E9Q38665130-7CE64E03-E3D9-4231-8233-E0D5E50271E9Q38765830-A9F83E41-BA51-43A3-A227-4659FCDC6E26Q38843374-0D397436-22EC-4982-BDC4-504365FCC377Q39433750-BBBE477A-F08D-4E5C-8AFD-D65AA11D7046Q40501110-1442C684-4156-45B9-854E-AFDAFABC968A
P2860
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@ast
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@en
type
label
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@ast
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@en
prefLabel
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@ast
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@en
P2093
P2860
P50
P1433
P1476
Viral linkage in HIV-1 serocon ...... V-1 prevention clinical trial.
@en
P2093
Dana N Raugi
Dana Panteleeff
Erin Kahle
Jairam R Lingappa
James I Mullins
James P Hughes
Jan Albert
Jared M Baeten
Julia N Stoddard
P2860
P304
P356
10.1371/JOURNAL.PONE.0016986
P407
P50
P577
2011-03-02T00:00:00Z